These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 23811951)
1. HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy. Guzmán-Fulgencio M; Berenguer J; Rallón N; Fernández-Rodríguez A; Miralles P; Soriano V; Jiménez-Sousa MA; Cosín J; Medrano J; García-Álvarez M; López JC; Benito JM; Resino S AIDS; 2013 May; 27(8):1231-8. PubMed ID: 23811951 [TBL] [Abstract][Full Text] [Related]
2. Effect of aging, glucose level, and HIV viral load on response to treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected women. Nasta P; Maida I; Cattelan AM; Pontali E; Angeli E; Giralda M; Verucchi G; Caputo A; Iannacone C; Puoti M; Carosi G J Womens Health (Larchmt); 2015 Feb; 24(2):159-64. PubMed ID: 25682817 [TBL] [Abstract][Full Text] [Related]
3. CXCL9, CXCL10 and CXCL11 polymorphisms are associated with sustained virologic response in HIV/HCV-coinfected patients. Pineda-Tenor D; Berenguer J; Jiménez-Sousa MA; Guzmán-Fulgencio M; Aldámiz-Echevarria T; Carrero A; García-Álvarez M; Diez C; Tejerina F; Briz V; Resino S J Clin Virol; 2014 Nov; 61(3):423-9. PubMed ID: 25218243 [TBL] [Abstract][Full Text] [Related]
4. PPARγ2 Pro12Ala polymorphism is associated with sustained virological response in HIV/HCV-coinfected patients under HCV therapy. Fernández-Rodríguez A; Berenguer J; Rallón N; Jiménez-Sousa MA; López JC; Soriano V; García-Álvarez M; Cosín J; Martínez P; Guzmán-Fulgencio M; Miralles P; Miguel Benito J; Resino S J Acquir Immune Defic Syndr; 2014 Oct; 67(2):113-9. PubMed ID: 25072612 [TBL] [Abstract][Full Text] [Related]
5. Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study. Kovari H; Russmann S; Ledergerber B; Müller D; Rotger M; Velli P; Cavassini M; Ambrosioni J; Bregenzer A; Stöckle M; Bernasconi E; Rauch A; Speck RF; PLoS One; 2015; 10(7):e0133879. PubMed ID: 26218843 [TBL] [Abstract][Full Text] [Related]
6. Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients. Fernández-Rodríguez A; Rallón N; Berenguer J; Jiménez-Sousa MA; Cosín J; Guzmán-Fulgencio M; Restrepo C; Lopez JC; García-Álvarez M; Miralles P; Soriano V; Benito JM; Resino S AIDS; 2013 Jan; 27(2):163-73. PubMed ID: 23135173 [TBL] [Abstract][Full Text] [Related]
7. Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin. Monje-Agudo P; Castro-Iglesias A; Rivero-Juárez A; Martínez-Marcos F; Ortega-González E; Real LM; Pernas B; Merchante N; Cid P; Macías J; Merino MD; Rivero A; Mena A; Neukam K; Pineda JA; Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):1929-36. PubMed ID: 26155784 [TBL] [Abstract][Full Text] [Related]
8. TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients. Jiménez-Sousa MA; Rallón N; Berenguer J; Pineda-Tenor D; López JC; Soriano V; Guzmán-Fulgencio M; Cosín J; Retana D; García-Álvarez M; Miralles P; Benito JM; Resino S J Clin Virol; 2015 Apr; 65():62-7. PubMed ID: 25766991 [TBL] [Abstract][Full Text] [Related]
10. Association between IL7RA polymorphisms and the successful therapy against HCV in HIV/HCV-coinfected patients. Guzmán-Fulgencio M; Berenguer J; Pineda-Tenor D; Jiménez-Sousa MA; García-Álvarez M; Aldámiz-Echevarria T; Carrero A; Diez C; Tejerina F; Vázquez S; Briz V; Resino S Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):385-93. PubMed ID: 25236396 [TBL] [Abstract][Full Text] [Related]
11. Real life experience in treatment of HIV-1/HCV-coinfected patients with pegylated interferon alpha and ribavirin: predictors of SVR. Bruno G; Fasano M; Saracino A; Volpe A; Bartolomeo N; Ladisa N; Maggi P; Monno L; Angarano G New Microbiol; 2015 Jan; 38(1):21-7. PubMed ID: 25742144 [TBL] [Abstract][Full Text] [Related]
12. Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapy. Murdaca G; Contini P; Cagnati P; Marenco S; Pieri G; Lantieri F; Picciotto A; Puppo F Clin Exp Med; 2017 Feb; 17(1):93-100. PubMed ID: 26567007 [TBL] [Abstract][Full Text] [Related]
13. Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients. Rallon NI; Lopez-Fernandez LA; Garcia MI; Benguria A; Fiorante S; Soriano V; Benito JM AIDS; 2013 Mar; 27(5):687-96. PubMed ID: 23196939 [TBL] [Abstract][Full Text] [Related]
14. Short Communication: CXCL12 rs1029153 Polymorphism Is Associated with the Sustained Virological Response in HIV/Hepatitis C Virus-Coinfected Patients on Hepatitis C Virus Therapy. Pineda-Tenor D; Jiménez-Sousa MA; Rallón N; Berenguer J; Soriano V; Aldámiz-Echevarria T; García-Álvarez M; Diez C; Fernández-Rodríguez A; Benito JM; Resino S AIDS Res Hum Retroviruses; 2016 Mar; 32(3):226-31. PubMed ID: 26499461 [TBL] [Abstract][Full Text] [Related]
15. OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy. Bruno R; Cariti G; Nasta P; Capetti A; Ravasio V; Galli M; Raise E; Palmieri G; Iannacone C; Puoti M Liver Int; 2015 Jan; 35(1):120-9. PubMed ID: 25041136 [TBL] [Abstract][Full Text] [Related]
16. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C. Martin-Carbonero L; Nuñez M; Mariño A; Alcocer F; Bonet L; García-Samaniego J; López-Serrano P; Cordero M; Portu J; Soriano V AIDS; 2008 Jan; 22(1):15-21. PubMed ID: 18090387 [TBL] [Abstract][Full Text] [Related]
17. Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study. Castells L; Rimola A; Manzardo C; Valdivieso A; Montero JL; Barcena R; Abradelo M; Xiol X; Aguilera V; Salcedo M; Rodriguez M; Bernal C; Suarez F; Antela A; Olivares S; Del Campo S; Laguno M; Fernandez JR; de la Rosa G; Agüero F; Perez I; González-García J; Esteban-Mur JI; Miro JM; J Hepatol; 2015 Jan; 62(1):92-100. PubMed ID: 25127748 [TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients. Dai CY; Chuang WL; Hsieh MY; Huang JF; Lin YY; Chu PY; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML Antiviral Res; 2010 Feb; 85(2):396-402. PubMed ID: 19931565 [TBL] [Abstract][Full Text] [Related]
19. Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients. Mira JA; Valera-Bestard B; Arizcorreta-Yarza A; González-Serrano M; Torre-Cisneros J; Santos I; Vergara S; Gutiérrez-Valencia A; Girón-González JA; Macías J; López-Cortés LF; Pineda JA Antivir Ther; 2007; 12(4):523-9. PubMed ID: 17668561 [TBL] [Abstract][Full Text] [Related]
20. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection. Jiménez-Sousa MA; Berenguer J; Rallón N; Pineda-Tenor D; Aldamiz-Echevarria T; Soriano V; García-Álvarez M; Vazquez-Morón S; Restrepo C; Carrero A; Benito JM; Resino S Liver Int; 2016 Sep; 36(9):1258-66. PubMed ID: 26836972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]